AR066892A1 - Derivados de benzoxazolona, proceso, medicamento, uso para tratar tumores y kit - Google Patents
Derivados de benzoxazolona, proceso, medicamento, uso para tratar tumores y kitInfo
- Publication number
- AR066892A1 AR066892A1 ARP080102415A ARP080102415A AR066892A1 AR 066892 A1 AR066892 A1 AR 066892A1 AR P080102415 A ARP080102415 A AR P080102415A AR P080102415 A ARP080102415 A AR P080102415A AR 066892 A1 AR066892 A1 AR 066892A1
- Authority
- AR
- Argentina
- Prior art keywords
- mnha
- mnh2
- hal
- mnaa
- conh
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Abstract
Los compuestos de la formula 1 en donde E, E', Eö, Eö' son, de modo independiente entre sí, C o N, R1, R2 son, de modo independiente entre sí, H o A, R1 y R2 también son juntos (CH2)p, en donde 1 o 2 CH2 pueden estar reemplazados por O y/o NH, R3 es H, (CH2)nCONH2, (CH2)nCONHA, (CH2)nCONAA', A, COA, OH, OA, CONH(CH2)mNH2, CONH(CH2)mNHA, CONH(CH2)mNAA', CO(CH2)mNH2, CO(CH2)mNHA, CO(CH2)mNAA', CO(CH2)mHet, CH(OH)A, CN, Het, Hal, CONH(CH2)mNA-COOA, SO2A, - NH(CH2)mNH2, NH(CH2)mNHA, NH(CH2)mNAA', (CH2)nCOOH, (CH2)nCOOA, O(CH2)mNH2, O(CH2)mNHA, O(CH2)mNAA', OHet, N=CH-NAA', N=CH-NHA, N=CH-NH2, O(CH2)mHet, O(CH2)mOH, O(CH2)mOA, SO2(CH2)mOH, OCH(A)CH2Het, OCH2CH(OH)CH2NHA, OCH2C(AA')CH2NAA', OCH2CH(A)CH2NAA', OCH2CH(OH)CH2OH, O(CH2)mCONAA' u O(CH2)mCOHet, R3' es H o Hal, R4 es Het1, NHCOOR5, NHCONHR5, NHCOCONHR5, NO2 o NHCOA, R4' es H o Hal, R4 y R4' también son juntos NHCONH, R5 es A, (CH2)mNH2, (CH2)mNHA, (CH2)NAA' o (CH2)mHet, Het es un heterociclo saturado, insaturado o aromático mono- o bicíclico con 1 a 4 átomos de N, O y/o S, que no está sustituido o que puede estar mono-, di- o trisustituido con Hal, A, OR6, N(R6)2, NO2, CN, COOR6, CON(R6)2, NR3COA, NR6SO2A, SO2N(R6)2, piridilo, S(O)mA, NHCOOA, NHCON(R6)2, CHO, COA, =S, =NH, =NA y/u =O (oxígeno de carbonilo), Het1 es un heterociclo aromático monocíclico con 1 a 4 átomos de N, O y/o S, que no está sustituido o que puede estar mono-, di- o trisustituido, de modo independiente entre sí, con R3; R6 es H o A; A, A' son, de modo independiente entre sí, alquilo no ramificado o ramificado C1-10, en donde 1-7 átomos de H se pueden reemplazar con OH, F, Cl y/o Br, y/o en donde uno o dos grupos CH2 pueden estar reemplazados por O, S, SO, SO2 y/o grupos CH=CH, o alquilo cíclico C3-7, Hal es F, Cl, Br o I, m es 1, 2, 3 o 4, n es 0, 1, 2, 3 o 4, p es 1, 2, 3, 4 o 5, y, en caso de que R3 esté unido a E' y R3' a E'', R3 y R3' también son juntos CH=CH-CH=CH, así como sus derivados, solvatos, sales, tautomeros y estereoisomeros de utilidad farmacéutica, incluyendo sus mezclas en todas las proporciones. Son inhibidores de las tirosina quinasas, en especial de la Metquinasa, y pueden utilizarse, por ejemplo, para el tratamiento de tumores.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007026341A DE102007026341A1 (de) | 2007-06-06 | 2007-06-06 | Benzoxazolonderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
AR066892A1 true AR066892A1 (es) | 2009-09-16 |
Family
ID=39739806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102415A AR066892A1 (es) | 2007-06-06 | 2008-06-06 | Derivados de benzoxazolona, proceso, medicamento, uso para tratar tumores y kit |
Country Status (18)
Country | Link |
---|---|
US (2) | US8071593B2 (es) |
EP (1) | EP2150551B1 (es) |
JP (1) | JP5662143B2 (es) |
KR (1) | KR20100031531A (es) |
CN (1) | CN101679401B (es) |
AR (1) | AR066892A1 (es) |
AU (1) | AU2008258366B2 (es) |
BR (1) | BRPI0812293A2 (es) |
CA (1) | CA2689554C (es) |
DE (1) | DE102007026341A1 (es) |
EA (1) | EA200901611A1 (es) |
ES (1) | ES2402540T3 (es) |
IL (1) | IL202505A (es) |
MX (1) | MX2009013077A (es) |
PE (1) | PE20090770A1 (es) |
TW (1) | TW200848030A (es) |
WO (1) | WO2008148449A1 (es) |
ZA (1) | ZA201000085B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007038957A1 (de) * | 2007-08-17 | 2009-02-19 | Merck Patent Gmbh | 6-Thioxo-pyridazinderivate |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008019907A1 (de) * | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
ES2376404T3 (es) * | 2008-05-22 | 2012-03-13 | Amgen Inc. | Heterociclos como inhibidores de proteínas cinasas. |
DE102008028905A1 (de) * | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
DE102008037790A1 (de) * | 2008-08-14 | 2010-02-18 | Merck Patent Gmbh | Bicyclische Triazolderivate |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
EP2326631A4 (en) * | 2008-08-18 | 2012-03-21 | Univ Yale | MODULATORS OF MIF |
JP5690741B2 (ja) | 2008-12-22 | 2015-03-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 新規な多形形態の6−(1−メチル−1h−ピラゾール−4−イル)−2−{3−[5−(2−モルホリン−4−イル−エトキシ)−ピリミジン−2−イル]−ベンジル}−2h−ピリダジン−3−オンジヒドロゲンホスファートおよびその製造方法 |
DE102009003975A1 (de) | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Benzothiazolonderivate |
WO2012003338A1 (en) | 2010-07-01 | 2012-01-05 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
US20140243302A1 (en) | 2011-06-27 | 2014-08-28 | Merck Sharp & Dohme Corporation | Bridged bicyclic compounds for the treatment of bacterial infections |
CN103242345B (zh) * | 2012-09-14 | 2015-03-11 | 日出实业集团有限公司 | 甲基吡啶磷中间体6-氯噁唑[4,5-b]吡啶-2(3H)酮的合成方法 |
AR095883A1 (es) * | 2013-04-18 | 2015-11-18 | Astellas Pharma Inc | Compuestos de acetamida heterocíclica |
WO2014200872A1 (en) * | 2013-06-09 | 2014-12-18 | Rjs Biologics Llc | Pharmaceutical compounds targeted by mif affinity-tethered moieties |
WO2016091891A1 (en) | 2014-12-09 | 2016-06-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Human monoclonal antibodies against axl |
WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
KR101798840B1 (ko) | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
JP2020524718A (ja) * | 2017-06-22 | 2020-08-20 | キュラデブ・ファーマ・リミテッドCuradev Pharma Limited | ヒトstingの複素環式小分子調節因子 |
US11180480B2 (en) | 2017-10-17 | 2021-11-23 | Sensorion | Synthesis of 4-aminopyrimidine compounds |
WO2020186202A1 (en) * | 2019-03-14 | 2020-09-17 | Board Of Regents, The University Of Texas System | Small molecule grb2 stabilizers for ras map kinase inhibition |
CN115490578B (zh) * | 2022-09-23 | 2023-12-22 | 江苏理工学院 | 一种碳同位素标记的三氯生的制备方法 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS421467B1 (es) * | 1963-11-28 | 1967-01-24 | ||
DE3904797A1 (de) | 1989-02-17 | 1990-08-30 | Merck Patent Gmbh | Nichtlinear optische materialien mit vicinalen donor- und akzeptorgruppen |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
DE19604388A1 (de) | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
US6184225B1 (en) | 1996-02-13 | 2001-02-06 | Zeneca Limited | Quinazoline derivatives as VEGF inhibitors |
DE69709319T2 (de) | 1996-03-05 | 2002-08-14 | Astrazeneca Ab | 4-anilinochinazolin derivate |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
JPH10259176A (ja) * | 1997-03-17 | 1998-09-29 | Japan Tobacco Inc | 血管新生阻害作用を有する新規アミド誘導体及びその用途 |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
AUPQ462299A0 (en) | 1999-12-13 | 2000-01-13 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
US6242461B1 (en) * | 2000-01-25 | 2001-06-05 | Pfizer Inc. | Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
JP2003535078A (ja) | 2000-05-31 | 2003-11-25 | アストラゼネカ アクチボラグ | 血管損傷活性のあるインドール誘導体 |
EP1301498A1 (en) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
GB0017676D0 (en) * | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
US6599902B2 (en) | 2001-05-30 | 2003-07-29 | Sugen, Inc. | 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
CN100415720C (zh) | 2001-06-22 | 2008-09-03 | 麒麟医药株式会社 | 喹啉衍生物和喹唑啉衍生物以及含有这些化合物的药物组合物 |
CA2462525A1 (en) | 2001-10-31 | 2003-05-08 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Type 4 phosphodiesterase inhibitors and uses thereof |
JP2005516927A (ja) * | 2001-12-13 | 2005-06-09 | アボット・ラボラトリーズ | 癌治療用のキナーゼ阻害剤としての3−(フェニル−アルコキシ)−5−(フェニル)−ピリジン誘導体および関連化合物 |
ATE448207T1 (de) | 2002-03-08 | 2009-11-15 | Merck & Co Inc | Mitotische kinesin-hemmer |
UA77526C2 (en) | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
EP1572693A1 (en) * | 2002-12-20 | 2005-09-14 | Pharmacia Corporation | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
JP2007516180A (ja) | 2003-07-02 | 2007-06-21 | スゲン,インコーポレイティド | c−Met阻害薬としてのアリールメチルトリアゾロおよびイミダゾピラジン類 |
EP2609919A3 (en) | 2003-09-26 | 2014-02-26 | Exelixis, Inc. | c-Met modulators and methods of use |
CA2572331A1 (en) | 2004-07-02 | 2006-02-09 | Exelixis, Inc. | C-met modulators and method of use |
DE102004036581A1 (de) | 2004-07-28 | 2006-03-23 | Robert Bosch Gmbh | Verfahren zum Betreiben eines Hybridantriebs und Vorrichtung zur Durchführung des Verfahrens |
US20070015771A1 (en) | 2004-07-29 | 2007-01-18 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
US20070043057A1 (en) | 2005-02-09 | 2007-02-22 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
CH697191A5 (de) | 2004-07-29 | 2008-06-25 | Biospectra Ag | Mehrfach-Bioreaktorvorrichtung. |
WO2006015263A2 (en) | 2004-07-29 | 2006-02-09 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
EP1621785A1 (en) | 2004-07-30 | 2006-02-01 | Mecos Traxler AG | Method and apparatus for controlling a magnetic bearing device |
NZ552946A (en) | 2004-08-26 | 2010-09-30 | Pfizer | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
DE102005038537A1 (de) | 2005-08-16 | 2007-02-22 | Merck Patent Gmbh | 1-Acyldihydropyrazolderivate |
WO2007044796A2 (en) | 2005-10-11 | 2007-04-19 | Nps Pharmaceuticals, Inc. | Pyridazinone compounds as calcilytics |
DE102005055355A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
DE102005055354A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine |
EP1963329B1 (en) | 2005-11-30 | 2013-01-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
DE102005057924A1 (de) | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
ME02736B (me) | 2005-12-21 | 2017-10-20 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
WO2007130383A2 (en) | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
NL2000613C2 (nl) | 2006-05-11 | 2007-11-20 | Pfizer Prod Inc | Triazoolpyrazinederivaten. |
PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
EP2205561A2 (en) | 2007-10-16 | 2010-07-14 | Novartis Ag | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
CA2703653A1 (en) | 2007-10-25 | 2009-04-30 | Astrazeneca Ab | Pyridine and pyrazine derivatives -083 |
CA2699631A1 (en) | 2007-10-31 | 2009-05-07 | Nissan Chemical Industries, Ltd. | Pyridazinone compounds and p2x7 receptor inhibitors |
US8859580B2 (en) | 2007-11-16 | 2014-10-14 | Boehringer Ingelheim International Gmbh | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
US8202996B2 (en) | 2007-12-21 | 2012-06-19 | Bristol-Myers Squibb Company | Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
KR101204213B1 (ko) | 2007-12-21 | 2012-11-26 | 에프. 호프만-라 로슈 아게 | 오렉신 수용체 길항제로서의 헤테로아릴 유도체 |
GB0725059D0 (en) | 2007-12-21 | 2008-01-30 | Syngenta Participations Ag | Novel pyridazine derivatives |
EP2072506A1 (de) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine oder Thiadiazolyloxyphenylamidine und deren Verwendung als Fungizide |
RU2495878C2 (ru) | 2007-12-21 | 2013-10-20 | Ф.Хоффманн-Ля Рош Аг | Гетероциклические антивирусные соединения |
CL2008003785A1 (es) | 2007-12-21 | 2009-10-09 | Du Pont | Compuestos derivados de piridazina; composiciones herbicidas que comprenden a dichos compuestos; y método para controlar el crecimiento de la vegetación indeseada. |
PE20091339A1 (es) | 2007-12-21 | 2009-09-26 | Glaxo Group Ltd | Derivados de oxadiazol con actividad sobre receptores s1p1 |
US7816540B2 (en) | 2007-12-21 | 2010-10-19 | Hoffmann-La Roche Inc. | Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
CN101903385B (zh) | 2007-12-21 | 2013-11-06 | 帕劳制药股份有限公司 | 作为组胺h4受体拮抗剂的4-氨基嘧啶衍生物 |
WO2009080364A1 (en) | 2007-12-21 | 2009-07-02 | Synthon B.V. | Raloxifene composition |
CN101952286A (zh) | 2007-12-21 | 2011-01-19 | 阿斯利康(瑞典)有限公司 | 用于治疗和雄激素受体有关的病症的双环衍生物 |
PE20091669A1 (es) | 2007-12-21 | 2009-12-06 | Exelixis Inc | Benzofuropirimidinonas |
CN101538245B (zh) | 2008-03-18 | 2011-02-16 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物及其制备方法和制备药物的用途 |
DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
EP2328586A2 (en) | 2008-05-20 | 2011-06-08 | Cephalon, Inc. | Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
US8487094B2 (en) | 2008-07-25 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
JP5253143B2 (ja) | 2008-12-26 | 2013-07-31 | キヤノン株式会社 | 情報処理装置、情報処理装置の制御方法、及びプログラム |
BRPI1013159A2 (pt) | 2009-03-30 | 2015-09-15 | Sumitomo Chemical Co | Uso de composto de piridazinona para controle de peste artrópode |
AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
-
2007
- 2007-06-06 DE DE102007026341A patent/DE102007026341A1/de not_active Withdrawn
-
2008
- 2008-05-08 KR KR1020107000014A patent/KR20100031531A/ko not_active Application Discontinuation
- 2008-05-08 ES ES08749391T patent/ES2402540T3/es active Active
- 2008-05-08 US US12/663,206 patent/US8071593B2/en not_active Expired - Fee Related
- 2008-05-08 CA CA2689554A patent/CA2689554C/en active Active
- 2008-05-08 EP EP08749391A patent/EP2150551B1/de active Active
- 2008-05-08 AU AU2008258366A patent/AU2008258366B2/en not_active Ceased
- 2008-05-08 WO PCT/EP2008/003696 patent/WO2008148449A1/de active Application Filing
- 2008-05-08 CN CN2008800183950A patent/CN101679401B/zh active Active
- 2008-05-08 JP JP2010510658A patent/JP5662143B2/ja active Active
- 2008-05-08 MX MX2009013077A patent/MX2009013077A/es not_active Application Discontinuation
- 2008-05-08 BR BRPI0812293-8A2A patent/BRPI0812293A2/pt not_active IP Right Cessation
- 2008-05-08 EA EA200901611A patent/EA200901611A1/ru unknown
- 2008-06-05 PE PE2008000958A patent/PE20090770A1/es not_active Application Discontinuation
- 2008-06-06 TW TW097121279A patent/TW200848030A/zh unknown
- 2008-06-06 AR ARP080102415A patent/AR066892A1/es unknown
-
2009
- 2009-12-03 IL IL202505A patent/IL202505A/en active IP Right Grant
-
2010
- 2010-01-05 ZA ZA201000085A patent/ZA201000085B/xx unknown
-
2011
- 2011-07-06 US US13/177,261 patent/US8431572B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2008258366B2 (en) | 2013-02-21 |
TW200848030A (en) | 2008-12-16 |
DE102007026341A1 (de) | 2008-12-11 |
AU2008258366A1 (en) | 2008-12-11 |
EP2150551B1 (de) | 2013-01-16 |
CA2689554C (en) | 2015-12-01 |
EA200901611A1 (ru) | 2010-06-30 |
EP2150551A1 (de) | 2010-02-10 |
CN101679401B (zh) | 2012-12-12 |
CA2689554A1 (en) | 2008-12-11 |
US8431572B2 (en) | 2013-04-30 |
BRPI0812293A2 (pt) | 2014-11-25 |
IL202505A (en) | 2014-11-30 |
PE20090770A1 (es) | 2009-06-24 |
MX2009013077A (es) | 2010-01-15 |
US20110263596A1 (en) | 2011-10-27 |
CN101679401A (zh) | 2010-03-24 |
ZA201000085B (en) | 2010-09-29 |
US8071593B2 (en) | 2011-12-06 |
IL202505A0 (en) | 2010-06-30 |
US20100280030A1 (en) | 2010-11-04 |
WO2008148449A1 (de) | 2008-12-11 |
JP2010529051A (ja) | 2010-08-26 |
JP5662143B2 (ja) | 2015-01-28 |
ES2402540T3 (es) | 2013-05-06 |
KR20100031531A (ko) | 2010-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR066892A1 (es) | Derivados de benzoxazolona, proceso, medicamento, uso para tratar tumores y kit | |
AR066543A1 (es) | Derivados de piridazinona | |
AR057214A1 (es) | Derivados de piridazinona como inhibidores, reguladores o moduladores de quinasas. | |
AR072860A1 (es) | Derivados de 3-(3-pirimidin-2-il-bencil)-[1,2,4]triazolo[4,3-b]piridazina | |
AR069843A1 (es) | Derivados de piridazinona, procedimiento para preparar dichos compuestos, composiciones farmaceuticas y usos de los mismos para preparar un medicamento | |
AR068658A1 (es) | Derivados de tiazol | |
AR071208A1 (es) | Derivados de piridazinona | |
AR076006A1 (es) | Compuestos heterociclicos inhibidores de autotaxina utiles para el tratamiento de tumores, proceso para prepararlos y medicamentos que los contienen. | |
AR067506A1 (es) | Derivados de quinazolinamida | |
AR068657A1 (es) | Derivados de piperidina y piperazina | |
AR059488A1 (es) | Hidrazidas de acido mandelico | |
AR068659A1 (es) | Derivados de imidazol inhibidores de autotaxina | |
AR074418A1 (es) | Compuestos de benzonaftiridina, procedimiento de preparacion y su uso en el tratamiento de tumores | |
AR073055A1 (es) | Derivados biciclicos de triazol | |
AR077567A1 (es) | Derivados de aminopiridina | |
AR066770A1 (es) | Derivados de piridazinona | |
CO6170361A2 (es) | Composiciones y metodos para modular receptores de c-kit y pdgfr | |
AR072192A1 (es) | Derivados de tiazolil-piperidina | |
AR058205A1 (es) | 5-fenil-3,6-dihidro-2-oxo-6h-[1,3,4] tiadiazinas sustituidas | |
AR082109A1 (es) | Derivados de bipiridilo | |
AR068872A1 (es) | 5- ciano- tienopiridinas. procesos de obtencion y composiciones farmaceuticas. | |
AR061735A1 (es) | Derivados de indazol, composiciones farmaceuticas y uso de los mismos | |
AR072792A1 (es) | DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS | |
AR059621A1 (es) | Acidos 4- fenil- tiazol-5- carboxilicos y amidas de acidos 4- fenil- tiazol5 carboxilicos como inhibidores de la plk1 | |
AR070540A1 (es) | Derivados de 6-oxo-5, 6-dihidro-benzo[c][1, 8]naftiridina, un proceso para su preparacion, un kit que los incluye y su uso en la fabricacion de medicamentos para el tratamiento del cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |